AKT1 and hepatocellular carcinoma: Prior investigation showed that leptin promotes hepatocellular carcinoma growth, invasiveness, and migration through concomitant activation of the JAK/STAT, PI3K/AKT and ERK signaling, which implicates the JAK/STAT pathway as a critical mediator of leptin action (Saxena et al., 2007).